Bio Impact Capital LLC Iovance Biotherapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
A detailed history of Bio Impact Capital LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 2,673,905 shares of IOVA stock, worth $15.5 Million. This represents 2.96% of its overall portfolio holdings.
Number of Shares
2,673,905
Previous 2,406,714
11.1%
Holding current value
$15.5 Million
Previous $22.6 Million
12.45%
% of portfolio
2.96%
Previous 3.53%
Shares
10 transactions
Others Institutions Holding IOVA
# of Institutions
340Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$159 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$141 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$128 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$123 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$70.8 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $912M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...